USP19调节了DNA甲基化损伤的修复,并通过MGMT稳定赋予了temozolomide耐药性
Jiaqi Liu1,2, Kaikai Wang3, Qian Zhu4
1Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
CNS neuroscience & therapeutics
|April 22, 2024
概括
USP19 deubiquitinates MGMT,增强DNA修复和质母细胞瘤中的泰莫索洛米德耐药性. 抑制USP19可能会恢复质母细胞瘤患者的化疗敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质母细胞瘤 (GBM) 经常会对泰莫索洛米德 (TMZ) 化疗产生耐药性.
- 甲基转移酶 (MGMT) 是一种关键的DNA修复酶,与TMZ耐药性有关.
- 在MGMT调节和TMZ反应中二维基因酶的作用仍然不完全理解.
研究的目的:
- 调查USP19和MGMT在GBM中TMZ治疗的背景下之间的关系.
- 为了确定USP19是否与MGMT直接相互作用,并对MGMT进行二氧化化.
- 评估USP19对GBM细胞对TMZ敏感性的影响及其与患者预后的相关性.
主要方法:
- 选一个二维基因酶面板来识别USP19作为MGMT相互作用的蛋白质.
- 实验室二化试验证实USP19在MGMT二化中的作用.
- 基于细胞的测定 (殖民地形成,异种移植瘤生长) 使用GBM细胞系 (T98G,LN18,U251,U87).
- 在GBM患者样本上进行免疫组织化学和生存分析.
主要成果:
- USP19直接与MGMT相互作用,并消除其无处不在,促进DNA甲基化损伤的修复.
- 消耗USP19使质母细胞细胞对temozolomide敏感,这是MGMT过度表达可逆的效应.
- 在GBM患者样本中,USP19过度表达,与MGMT蛋白水平呈正相关,表明预后不佳.
结论:
- 在GBM中,通过USP19调节MGMT泛基化对于DNA修复和temozolomide化疗反应至关重要.
- USP19代表了克服质母细胞瘤化学抵抗的潜在治疗标.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:37Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
02:37DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K